These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2636698)

  • 21. Circulating iodothyronines in juvenile diabetic outpatients.
    Schmitz O; Laurberg P; Weeke J
    Diabete Metab; 1980 Mar; 6(1):51-3. PubMed ID: 7371897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon kinetics in fasting: physiological elevations in serum 3,5,3'-triiodothyronine increase the metabolic clearance rate of glucagon.
    Burman KD; Smallridge RC; Jones L; Ramos EA; O'Brien JT; Wright FD; Wartofsky L
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1158-65. PubMed ID: 7419689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of the infusion of glucagon on the blood levels of thyroid hormones].
    Custro N; Scafidi V
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):521-8. PubMed ID: 2257119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the low-T3-syndrome and prognosis assessment in patients with liver cirrhosis.
    Rink C; Siersleben U; Haerting J; Mende T; Nilius R
    Gastroenterol J; 1991; 51(3-4):138-41. PubMed ID: 1811659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon does not modulate the alterations in T3 metabolism consequent to dietary manipulation and diabetes.
    Gavin LA; Moeller M
    Diabetes; 1983 Sep; 32(9):798-803. PubMed ID: 6354787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiles of plasma amino acids in fasted patients with various liver diseases.
    Fujinami S; Hijikata Y; Shiozaki Y; Sameshima Y
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():81-4. PubMed ID: 2083940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Circulating types of human glucagon (author's transl)].
    Valverde I
    MMW Munch Med Wochenschr; 1978 Mar; 120(12):407-9. PubMed ID: 306029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dietary protein intake on renal function in humans.
    Ando A; Kawata T; Hara Y; Yaegashi M; Arai J; Sugino N
    Kidney Int Suppl; 1989 Nov; 27():S64-7. PubMed ID: 2636675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease.
    Yilmaz MI; Sonmez A; Karaman M; Ay SA; Saglam M; Yaman H; Kilic S; Eyileten T; Caglar K; Oguz Y; Vural A; Yenicesu M; Zoccali C
    Am J Nephrol; 2011; 33(1):25-32. PubMed ID: 21150192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glucagon degrading activity].
    Wakasugi K
    Nihon Naibunpi Gakkai Zasshi; 1989 May; 65(5):483-96. PubMed ID: 2476336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Presence of big plasma glucagon in a woman with porphyria].
    Shimoyama R; Uehara S; Itagaki Y; Izumiyama S; Hirayama A; Sato T; Ishikura M
    Nihon Naika Gakkai Zasshi; 1983 May; 72(5):611-7. PubMed ID: 6644144
    [No Abstract]   [Full Text] [Related]  

  • 32. Free triiodothyronine, not thyroid stimulating hormone, should be focused on for risk stratification in acute decompensated heart failure.
    Kishi T
    J Cardiol; 2015 Sep; 66(3):201-2. PubMed ID: 26051635
    [No Abstract]   [Full Text] [Related]  

  • 33. Decline of T3 and elevation in reverse T3 induced by hyperglucagonemia: changes in thyroid hormone metabolism, not altered release of thyroid hormones.
    Kabadi UM; Premachandra BN
    Horm Metab Res; 1988 Aug; 20(8):513-6. PubMed ID: 3181870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in circulating lymphocyte triiodothyronine receptors in diabetes mellitus].
    Lu G
    Zhonghua Yi Xue Za Zhi; 1993 Sep; 73(9):517-9, 573. PubMed ID: 8313191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of high blood glucagon in the reduction of serum levels of triiodothyronine in severe non-thyroid diseases].
    Custro N; Scafidi V; Costanzo G; Calanni S
    Minerva Endocrinol; 1989; 14(4):221-6. PubMed ID: 2636698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
    Kabadi UM; Kabadi MU; Premachandra BN
    Am J Gastroenterol; 1991 Oct; 86(10):1504-7. PubMed ID: 1928046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon administration induces lowering of serum T3 and rise in reverse T3 in euthyroid healthy subjects.
    Kabadi UM; Premachandra BN
    Horm Metab Res; 1985 Dec; 17(12):667-70. PubMed ID: 3910531
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.